Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection

Hsu YC, Ho HJ, Huang YT, Wang HH, Wu MS, Lin JT, et al. Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Gut. 2015;64(3):495-503.

Publication Type:

Journal Article

Authors:

Hsu, Y.C.; Ho, H.J.; Huang, Y.T.; Wang, H.H.; Wu, M.S.; Lin, J.T.; Wu, C.Y.

Source:

Gut, Volume 64, Issue 3, p.495-503 (2015)

Keywords:

Acute Coronary Syndrome, Adult, Antiviral Agents, Autoimmune Diseases, China, Clinical Medicine, Cohort Studies, Comorbidity, complications, Disease, drug therapy, Drug Therapy,Combination, epidemiology, Female, Gastroenterology, HCV, Health, Health Policy, hepatitis, Hepatitis C, hepatitis C virus, Humans, Incidence, Infection, interferon, Interferon-alpha, Internal Medicine, Kidney Failure,Chronic, Life, Male, Medicine, methods, Middle Aged, Mortality, Patients, peginterferon, peginterferon alfa-2b, pegylated, pegylated interferon, Polyethylene Glycols, Proportional Hazards Models, Proteins, Public Health, Recombinant Proteins, Renal, Research, Research Support, Rhode Island, Ribavirin, Risk, Stroke, Syndrome, Taiwan, therapeutic use, therapy, treatment, Treatment Outcome, Universities, Veterans

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/25398770

Export Citation:

RIS Format

Top